Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Incineration of Pharmaceutical Waste

Posted on By

SOP for Incineration of Pharmaceutical Waste

Standard Operating Procedure for Incineration of Pharmaceutical Waste

1) Purpose

The purpose of this SOP is to provide clear guidelines for the safe and compliant incineration of pharmaceutical waste to ensure environmental safety, worker protection, and adherence to regulatory standards.

2) Scope

This SOP applies to all departments involved in the collection, storage, transportation, and incineration of pharmaceutical waste generated in manufacturing units, laboratories, warehouses, and healthcare facilities.

3) Responsibilities

  • Supervisors: Ensure proper implementation of pharmaceutical waste incineration procedures and compliance with regulatory requirements.
  • Operators: Collect, segregate, and transport waste to the incineration site as per this SOP.
  • Waste Management Personnel: Monitor and coordinate safe incineration with authorized facilities.
  • Safety Officers: Conduct audits and ensure adherence to environmental and safety standards.

4) Procedure

4.1 Classification of Pharmaceutical Waste

Pharmaceutical waste is categorized as follows:

  1. Expired Pharmaceuticals: Tablets, capsules, syrups, and injectable drugs.
  2. Contaminated Pharmaceuticals: Medicines exposed to contamination or spillage.
  3. Unusable Chemicals and Reagents: Expired reagents, solvents, and analytical chemicals.
  4. Sharps Waste: Syringes, needles, ampoules, and broken glassware containing drug residues.
  5. Hazardous Pharmaceutical Waste: Cytotoxic drugs, hormonal medicines, and antibiotics.
See also  SOP for Preparing EHS Budget and Financial Records

4.2 Segregation and Collection of Pharmaceutical Waste

  1. Segregation Process:
    • Segregate pharmaceutical waste at the point of generation into appropriate categories.
    • Do not mix hazardous pharmaceutical waste with general or non-hazardous waste.
  2. less
    Copy code

  3. Color-Coded Containers:
    • Red:
Contaminated and hazardous pharmaceutical waste
  • Yellow: Expired pharmaceuticals and cytotoxic drugs
  • White: Sharps waste (e.g., syringes, needles)
  • Labeling:
    • Clearly label all containers with:
      • Type of waste
      • Date of collection
      • Hazard warnings (e.g., Biohazard, Toxic, Flammable)
  • Documentation:
    • Record details of waste collected in the Pharmaceutical Waste Log (Annexure 1).
  • 4.3 Storage of Pharmaceutical Waste

    1. Storage Area Requirements:
      • Designate a secure, ventilated, and isolated area for temporary storage of pharmaceutical waste.
      • Ensure containers are leak-proof, sealed, and labeled appropriately.
    2. less
      Copy code

    3. Storage Duration:
      • Do not store pharmaceutical waste for more than 7 days before disposal.
    4. Safety Precautions:
      • Ensure no food or drink is consumed in the storage area.
      • Keep incompatible waste (e.g., flammable and reactive chemicals) stored separately.

    4.4 Transportation of Pharmaceutical Waste

    1. Internal Transportation:
      • Transport pharmaceutical waste using wheeled, spill-proof trolleys.
      • Ensure waste containers remain sealed during transportation.
    2. less
      Copy code

    3. External Transportation:
      • Engage authorized hazardous waste transport vendors for external transport.
      • Maintain transport manifests and ensure containers meet regulatory transport guidelines.

    4.5 Incineration of Pharmaceutical Waste

    Pharmaceutical waste must be disposed of through incineration at an authorized waste disposal facility:

    1. Approved Facilities:
      • Partner with government-approved incineration plants equipped for pharmaceutical waste disposal.
      • Verify the facility’s compliance with emission control standards.
    2. less
      Copy code

    3. Incineration Process:
      • Ensure the incinerator operates at a minimum of 850°C to destroy hazardous pharmaceuticals and 1200°C for cytotoxic waste.
      • Confirm emissions meet air quality standards as per CPCB (Central Pollution Control Board) and EPA guidelines.
    4. Disposal Verification:
      • Obtain disposal certificates from the incineration facility.
      • Document disposal activities in the Pharmaceutical Waste Disposal Log (Annexure 2).

    4.6 Emergency Preparedness

    1. Spill Response:
      • In case of pharmaceutical waste spills, isolate the area and notify the Safety Officer.
      • Use spill kits and absorbents to contain and clean the spill.
    2. less
      Copy code

    3. Fire Safety:
      • Ensure fire extinguishers (Class B) are readily available in the storage and incineration areas.
      • Conduct regular fire safety drills.

    4.7 Record-Keeping and Compliance

    1. Documentation:
      • Maintain records of pharmaceutical waste generation, storage, transportation, and disposal.
      • Retain disposal certificates for compliance audits.
    2. less
      Copy code

    3. Audit Compliance:
      • Conduct regular internal audits to ensure adherence to this SOP and regulatory standards.
      • Report any non-compliance to the Safety Officer for corrective action.

    5) Abbreviations, if any

    • PPE: Personal Protective Equipment
    • CPCB: Central Pollution Control Board
    • EPA: Environmental Protection Agency

    6) Documents, if any

    • Pharmaceutical Waste Log
    • Disposal Certificates
    • Waste Transport Manifests

    7) Reference, if any

    • Biomedical Waste Management Rules, 2016
    • EPA Hazardous Waste Guidelines
    • CPCB Emission Standards for Incinerators

    8) SOP Version

    Version: 1.0

    Annexure

    Template 1: Pharmaceutical Waste Log

     
    Date Waste Type Quantity Storage Location Handled By
    DD/MM/YYYY Expired Medicines 30 Kg Storage Room 2 John Doe

    Template 2: Disposal Log

     
    Date Waste Type Quantity Disposal Method Facility Name Certificate Number
    DD/MM/YYYY Cytotoxic Drugs 20 Kg High-Temperature Incineration XYZ Incineration Plant CERT-12345
    See also  SOP for Preparing Monthly EHS Performance Reports
    Environment, Health and Safety Tags:Emergency response for hazardous materials incidents, Hazardous materials classification, Hazardous materials compliance audits, Hazardous materials decontamination procedures, Hazardous materials disposal methods, Hazardous materials emergency planning, Hazardous materials emergency response guidebook, Hazardous materials exposure limits, Hazardous materials handling, Hazardous materials handling equipment, Hazardous materials incident command system, Hazardous materials incident reporting, Hazardous materials inventory management, Hazardous materials labeling requirements, Hazardous materials monitoring equipment, Hazardous materials packaging requirements, Hazardous materials placarding requirements, Hazardous materials regulatory agencies, Hazardous materials response team training, Hazardous materials risk assessment, Hazardous materials security plans, Hazardous materials shipping papers, Hazardous materials spill response, Hazardous materials storage guidelines, Hazardous materials training requirements, Hazardous materials transportation regulations, Hazardous materials transportation safety, Personal protective equipment for hazardous materials, Regulatory compliance in hazardous materials management, Safety procedures for hazardous materials

    Post navigation

    Previous Post: Tablets: SOP for Process Controls in Sustained Release Tablet Manufacturing – V 2.0
    Next Post: Ointments: SOP for pH Adjustment During Ointment Development – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version